NO20053612D0 - 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders - Google Patents

1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders

Info

Publication number
NO20053612D0
NO20053612D0 NO20053612A NO20053612A NO20053612D0 NO 20053612 D0 NO20053612 D0 NO 20053612D0 NO 20053612 A NO20053612 A NO 20053612A NO 20053612 A NO20053612 A NO 20053612A NO 20053612 D0 NO20053612 D0 NO 20053612D0
Authority
NO
Norway
Prior art keywords
treatment
nervous system
central nervous
system disorders
derivatives useful
Prior art date
Application number
NO20053612A
Other languages
Norwegian (no)
Other versions
NO20053612L (en
Inventor
Mario Rottlander
Morten Bang Norgaard
Christian Wenzel Tornoe
Andreas Ritzen
Nikolay Khanzhin
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053612(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20053612D0 publication Critical patent/NO20053612D0/en
Publication of NO20053612L publication Critical patent/NO20053612L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20053612A 2002-12-27 2005-07-25 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders NO20053612L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number Publication Date
NO20053612D0 true NO20053612D0 (en) 2005-07-25
NO20053612L NO20053612L (en) 2005-09-23

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053612A NO20053612L (en) 2002-12-27 2005-07-25 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders

Country Status (17)

Country Link
KR (1) KR20050089862A (en)
CN (1) CN100448867C (en)
AR (1) AR042656A1 (en)
BR (1) BR0317748A (en)
CL (1) CL2003002748A1 (en)
EA (1) EA008589B1 (en)
HK (1) HK1088317A1 (en)
IS (1) IS2649B (en)
MY (1) MY139844A (en)
NO (1) NO20053612L (en)
PE (1) PE20041015A1 (en)
PL (1) PL377221A1 (en)
SI (1) SI1578740T1 (en)
TW (1) TWI325414B (en)
UA (1) UA79666C2 (en)
UY (1) UY28151A1 (en)
ZA (1) ZA200504565B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (en) * 1992-01-08 1993-07-15 Asta Medica Ag NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE19539861A1 (en) * 1995-10-26 1997-04-30 Asta Medica Ag Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
AR042656A1 (en) 2005-06-29
EA008589B1 (en) 2007-06-29
MY139844A (en) 2009-11-30
ZA200504565B (en) 2006-08-30
PL377221A1 (en) 2006-01-23
UY28151A1 (en) 2004-07-30
NO20053612L (en) 2005-09-23
HK1088317A1 (en) 2006-11-03
CN100448867C (en) 2009-01-07
TW200413280A (en) 2004-08-01
CL2003002748A1 (en) 2005-04-08
CN1732162A (en) 2006-02-08
PE20041015A1 (en) 2005-01-08
IS2649B (en) 2010-08-15
SI1578740T1 (en) 2007-08-31
TWI325414B (en) 2010-06-01
UA79666C2 (en) 2007-07-10
BR0317748A (en) 2005-11-22
EA200501053A1 (en) 2005-12-29
KR20050089862A (en) 2005-09-08
IS7856A (en) 2005-05-23

Similar Documents

Publication Publication Date Title
NO20053384D0 (en) Benzazepine derivatives for the treatment of neurological disorders.
NO20043237L (en) Dihydrobenzodiazepine-2-derivatives for the treatment of neurological disorders
NO20055098D0 (en) Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
NO20026263L (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
AU2003249983A1 (en) Piperidines useful for the treatment of central nervous system disorders
EE200100441A (en) Monoamine reuptake inhibitors for the treatment of central nervous system disorders
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
IL176581A0 (en) Immunomodulatory compounds for the treatment of central nervous system disorders
NO20053211D0 (en) Compounds for the treatment of metabolic disorders.
NO20041386L (en) Combinations for the treatment of immuno-inflammatory disorders
DK1578740T3 (en) 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders
DK1339406T3 (en) Piperazine derivatives, processes for their preparation and use thereof for the treatment of central nervous system disorders
NO20043085L (en) Methods and compositions for the treatment of central nervous system disorders
HK1080859A1 (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
DK1309322T3 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
ATE256126T1 (en) 5-HETEROATOM-ALKYL SUBSTITUTED 3-OXO-PYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
NO20011892L (en) 3-tetrahydropyridin-4-yl indoles for the treatment of psychotic disorders
NO20026005D0 (en) Indole derivatives useful for the treatment of CNS disorders
IS2172B (en) Indole derivatives useful for the treatment of nervous system disorders
NO20012612D0 (en) Isonipecotamides for the treatment of integrin-mediated disorders
IS6098A (en) Incantant for the treatment of mood disorders
NO20053612D0 (en) 1,2,4-triaminobenzene derivatives useful for the treatment of central nervous system disorders
NO20026029L (en) Indole derivatives useful for the treatment of CNS disorders
NO20012538D0 (en) Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders
NO20026028L (en) Indole derivatives useful for the treatment of CNS disorders

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application